What Is It?
Three peptides from the same gene family, plus one lab-built hybrid. Your body already makes GLP-1 and GLP-2 — different organs read the same gene and produce different peptides.
How Does It Work?
Imagine one cookbook with several recipes inside. Different kitchens read the same cookbook but make different dishes. Pancreas makes glucagon. Gut makes GLP-1 and GLP-2. Same cookbook. Different chef. Different meal.
Compounds Covered
- GLP-1 (Semaglutide, Tirzepatide) — Appetite suppression, insulin regulation. ~15-22% weight loss. FDA-approved (Ozempic, Wegovy, Mounjaro, Zepbound).
- GLP-2 (Teduglutide) — Intestinal growth and repair. FDA-approved for short bowel syndrome (Gattex).
- GLP-3 / Retatrutide — Triple agonist (GLP-1 + GIP + glucagon). ~28.7% weight loss in Phase 3. FDA approval projected 2027.
Run the Numbers
Compare reconstitution math across GLP peptides — BAC water volume, syringe units, and weekly dose totals. Free, no login required.
Open the Calculator →The Honest Part
- FDA black-box warning for thyroid tumor risk.
- Other risks: pancreatitis, gallbladder disease, gastroparesis.
- "Ozempic face" (facial fat loss).
- Suicidal ideation under FDA investigation.
- Only branded versions are FDA-regulated — compounded versions lack quality guarantees.
- For research purposes only when discussing non-approved compounds.
Track GLP Peptides in the App
Peptide Manager Pro tracks 100+ compounds with an interactive knowledge graph, dosing calculator, protocol tracker, and AI research chat. Veteran-owned. $4.99/mo founding rate.
Get the App →